ArticleInternational journal of molecular sciences2023

Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.

Narayan Shivapurkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.